More Men Needed in Breast Cancer Trials
Breast cancer is rare in men. About one percent of all breast cancer diagnoses are in men. However, when men are diagnosed, their cancer tends to be at a later...
Read MoreNew FDA Approval: A PI3K Inhibitor
In May, the U.S. Food and Drug Administration (FDA) approved Piqray® (alpelisib) for treating advanced breast cancer. It is approved for use in combination with...
Read MoreTrue or False?
You may be treated with only a placebo in a metastatic breast cancer clinical trial. Answer: False A patient with metastatic breast cancer will never...
Read MoreNew Guideline Includes Immunotherapy
In March, the immunotherapy Tecentriq® (atezolizumab) became the first to be included in NCCN Treatment Guidelines for metastatic breast cancer. It can be used...
Read MoreHow to Get a Medical Interpreter
Federal law requires that all health care organizations provide patients who speak little or no English with an interpreter. Providers that take Medicaid or...
Read MoreShould You Get A Second Opinion?
Whether you were diagnosed with MBC de novo or have experienced a metastatic recurrence, a second opinion can help you learn more about your treatment options as...
Read MoreWhat is Oligometastatic Breast Cancer?
Women and men with metastatic breast cancer are typically told their cancer can be treated but not cured. This is true for most patients. But there are some...
Read MoreDoctors & Patients on Clinical Trials
Many people diagnosed with cancer never consider entering a clinical trial. Yet clinical trials provide unique opportunities to receive high-quality care while...
Read MoreGenomic Testing: What Makes Your Tumor Grow?
The U.S. Food and Drug Administration (FDA) has approved two tests to identify genetic alterations in tumors. These tests, which are done on a tumor sample, look...
Read MoreSEARCH OUR SITE
for past articles or specific information.